RESMED INC - 18 Nov 2021 Form 4 Insider Report for RESMED INC (RMD)

Reporting relationship: Director
Issuer ticker: RMD
Reported as of: 18 Nov 2021
Net transaction value: $0
SEC form: 4
Accepted by SEC: 22 Nov 2021, 18:00:44 UTC
Source filing: View source filing
Reporting owner signature: Richard Sulpizio

Key filing fact

RESMED INC filed Form 4 for RESMED INC (RMD) on 22 Nov 2021.

Key facts

This page summarizes RESMED INC's Form 4 filing for RESMED INC (RMD).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 22 Nov 2021, 18:00.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RMD transaction

ResMed Common Stock

Award

Transaction value: $0
Shares: +956
Change %: +7.4%
Price: $0.000000
Shares after: 13,823
Date: 18 Nov 2021
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Shares awarded are restricted stock units. The RSUs vest on the earlier of November 11, 2022, or the annual shareholders meeting in the year following the grant date.